770 related articles for article (PubMed ID: 22703696)
1. Histoplasmosis in HIV-positive patients in Ceará, Brazil: clinical-laboratory aspects and in vitro antifungal susceptibility of Histoplasma capsulatum isolates.
Brilhante RS; Fechine MA; Mesquita JR; Cordeiro RA; Rocha MF; Monteiro AJ; Lima RA; Caetano ÉP; Pereira JF; Castelo-Branco DS; Camargo ZP; Sidrim JJ
Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):484-8. PubMed ID: 22703696
[TBL] [Abstract][Full Text] [Related]
2. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
[TBL] [Abstract][Full Text] [Related]
3. Hemichorea in a patient with HIV-associated central nervous system histoplasmosis.
Estrada-Bellmann I; Camara-Lemarroy CR; Flores-Cantu H; Calderon-Hernandez HJ; Villareal-Velazquez HJ
Int J STD AIDS; 2016 Jan; 27(1):75-7. PubMed ID: 25505048
[TBL] [Abstract][Full Text] [Related]
4. Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome.
Wheat LJ; Connolly P; Smedema M; Brizendine E; Hafner R;
Clin Infect Dis; 2001 Dec; 33(11):1910-3. PubMed ID: 11692303
[TBL] [Abstract][Full Text] [Related]
5. Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole.
Wheat LJ; Connolly P; Smedema M; Durkin M; Brizendine E; Mann P; Patel R; McNicholas PM; Goldman M
J Antimicrob Chemother; 2006 Jun; 57(6):1235-9. PubMed ID: 16627592
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of the treatment and secondary antifungal prophylaxis in AIDS-related histoplasmosis. Experience at the Francisco J. Muñiz Infectious Diseases Hospital in Buenos Aires].
Negroni R; Messina F; Arechavala A; Santiso G; Bianchi M
Rev Iberoam Micol; 2017; 34(2):94-98. PubMed ID: 28391953
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
Drew RH
Ann Pharmacother; 1993 Dec; 27(12):1510-8. PubMed ID: 8305787
[TBL] [Abstract][Full Text] [Related]
8. [Histoplasmosis: not only a tropical disease].
Bregani ER; Van Tien T; Ceraldi T; Delfitto C; Figini G
Recenti Prog Med; 2000; 91(7-8):396-401. PubMed ID: 10932927
[TBL] [Abstract][Full Text] [Related]
9. Disseminated histoplasmosis diagnosed in the bone marrow of an HIV-infected patient: First case imported in Tunisia.
Fakhfakh N; Abdelmlak R; Aissa S; Kallel A; Boudawara Y; Bel Hadj S; Ben Romdhane N; Touiri Ben Aissa H; Kallel K
J Mycol Med; 2018 Mar; 28(1):211-214. PubMed ID: 29519625
[TBL] [Abstract][Full Text] [Related]
10. [African histoplasmosis due to Histoplasma capsulatum var. duboisii: relationship with AIDS in recent Congolese cases].
Chandenier J; Goma D; Moyen G; Samba-Lefèbvre MC; Nzingoula S; Obengui ; Mbitsi A; Nkiwabonga L; Ngaporo AI
Sante; 1995; 5(4):227-34. PubMed ID: 7582643
[TBL] [Abstract][Full Text] [Related]
11. Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum.
Wheat J; Marichal P; Vanden Bossche H; Le Monte A; Connolly P
Antimicrob Agents Chemother; 1997 Feb; 41(2):410-4. PubMed ID: 9021199
[TBL] [Abstract][Full Text] [Related]
12. Detection of the 70-kilodalton histoplasma capsulatum antigen in serum of histoplasmosis patients: correlation between antigenemia and therapy during follow-up.
Gómez BL; Figueroa JI; Hamilton AJ; Diez S; Rojas M; Tobón A; Restrepo A; Hay RJ
J Clin Microbiol; 1999 Mar; 37(3):675-80. PubMed ID: 9986830
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum.
Kobayashi GS; Travis SJ; Rinaldi MG; Medoff G
Antimicrob Agents Chemother; 1990 Apr; 34(4):524-8. PubMed ID: 2344160
[TBL] [Abstract][Full Text] [Related]
14. A complementary tool for management of disseminated Histoplasma capsulatum var. capsulatum infections in AIDS patients.
Iriart X; Blanchet D; Menard S; Lavergne RA; Chauvin P; Adenis A; Cassaing S; Fillaux J; Magnaval JF; Demar M; Carme B; Bessieres MH; Couppie P; Nacher M; Berry A; Aznar C
Int J Med Microbiol; 2014 Nov; 304(8):1062-5. PubMed ID: 25201327
[TBL] [Abstract][Full Text] [Related]
15. Histoplasmosis: update 1998.
Brooks JT; Wheat LJ
AIDS Clin Care; 1998 Jan; 10(1):4-5. PubMed ID: 11365076
[TBL] [Abstract][Full Text] [Related]
16. [Leprosy-like cutaneous presentation of Histoplasma capsulatum infection in an African HIV+ patient].
Scarlata F; Imburgia C; Trizzino M; Titone L
Infez Med; 2012 Sep; 20(3):211-3. PubMed ID: 22992563
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Almyroudis NG; Sutton DA; Fothergill AW; Rinaldi MG; Kusne S
Antimicrob Agents Chemother; 2007 Jul; 51(7):2587-90. PubMed ID: 17452481
[TBL] [Abstract][Full Text] [Related]
18. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
[TBL] [Abstract][Full Text] [Related]
19. [Cutaneous Histoplasmosis and AIDS].
Reyes M; Arenas LR; Pichardo P; Vick R; Torres A; Zacarías R
Gac Med Mex; 2003; 139(3):270-5. PubMed ID: 12872420
[TBL] [Abstract][Full Text] [Related]
20. [Disseminated histoplasmosis in AIDS].
Albrecht H; Stellbrink HJ; Petersen J; Patzak A; Jäger H; Greten H
Dtsch Med Wochenschr; 1994 May; 119(18):657-62. PubMed ID: 8187612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
